An interventional study of Star to move Protocol in Intensive Care Unit Acquired Weakness, Intensive Care Unit Delirium and Intensive Care Neuropathy, sponsored by Hospital Felix Bulnes. Completed at 1 site in Chile. Open to participants aged 15 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-09-22.
Sponsored by Hospital Felix Bulnes · Not applicable, Interventional, and Treatment
Background: ICU hospitalization is associated with loss of strength, functionality and delirium. The "Start to Move protocol" demonstrated efficacy in improving and minimizing such effects.
Aim: To evaluate the effectiveness of the "Start to move protocol" compared with conventional treatment in ICU subjects on functionality, weakness acquired in the Intensive Care Unit (ICU-AW), incidence of delirium, days of invasive mechanical ventilation (IMV), ICU stay and 28-day mortality.
Methods: Randomized controlled clinical trial. Including adults ≥15 years with IMV >48 hours, randomized into Start to move and conventional treatment groups.Functionality, ICU-AW incidence, delirium incidence, IMV days, ICU stay and mortality-28 days were analyzed.
Introduction:
Individuals hospitalized in Intensive Care Units are subjected to a prolonged state of rest and to various factors that directly or indirectly affect the muscular and organic structure, which can result in ICU-acquired weakness (ICU-AW) and a limitation in functional performance.
These factors can be divided into metabolic, pharmacological and organic, where sustained hyperglycemia, corticosteroid use, sedation-analgesia, neuromuscular blockade and multiorgan failure associated with sepsis or septic shock stand out. This state translates into a direct loss of muscle mass, specifically of type II fibers, physiologically explained by an increase in the myosin protein degradation process, a decrease in protein synthesis and an increase in proinflammatory cells that favor the weakness of the critically ill patient.
Brower et al. studied that the effects of prolonged rest produce a deconditioning and atrophy of the musculature. After 14 days of immobilization, young people and adults are exposed to a 9% loss of quadriceps muscle mass, which translates into a loss of muscle strength of up to 27%.In subjects subjected to invasive mechanical ventilation, it has been shown that the cross-sectional area of the quadriceps muscle can decrease up to 12.5% in the first week of their stay in the ICU, which can increase up to 15.7% if they present multiorgan failure versus a 3% loss in subjects with single organ failure.
ICU-AW and loss of function are also directly related to the prolonged use of sedoanalgesia, neuromuscular blockade and a higher incidence of delirium in the ICU. The presence of delirium is related to low participation in physical therapies, either by decreased cooperation and/or psychomotor agitation, thus directly influencing muscle status and subsequent functional recovery.
Brummel et al. report that delirium is common in the ICU, affecting between 60-80% of subjects undergoing IMV and between 20-50% of subjects on noninvasive mechanical ventilation, increasing the risk of removal of invasive elements, accidental extubations and the need for physical restraints that may delay the onset of functional recovery.
To demonstrate the consequences of prolonged rest and quantify ICU-AW, the Medical Research Council (MRC) assessment scale is used, a validated tool which analytically measures the strength of six muscle groups bilaterally with a score of 30 points per hemibody, obtaining a total of 60 points. A score of 48 points or less determines the presence of ICU-AW.
On the other hand, the validated Functional Status Scale - Intensive Care Unit (FSS-ICU), which measures functional milestones with a score between 0 and 35 points, is commonly used to assess the functionality of the critically ill patient 12.
The aim of our study is to evaluate the effectiveness of the Start to move protocol compared to conventional ICU treatment on functionality, ICU-Aw, incidence of delirium, days of mechanical ventilation, ICU stay and 28-day mortality, Clínica Ensenada 2018 - 2019.
1,057 studies on the registry are indexed under Delirium; 238 are open to participants now.
This study's enrollment of 69 is below the median of 120 across 599 interventional studies indexed under Delirium.
Browse Delirium studies →This is the only study on the registry with Hospital Felix Bulnes as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
In the Start to move group, physical therapy was included according to the Gosselink protocol, which establishes 6 levels of care divided according to system stability and state of consciousness. At level 0, no physical mobilization therapy was applied due to systemic lability. From level 1 to 5, passive mobilizations, use of muscle electrostimulation, active mobilizations and exercises against resistance, application of conventional cycloergometer, up to walking with assistance if the subject is able to perform it.
Other: Star to move Protocol
In the conventional treatment group, passive mobilization, active-assisted mobilization and exercises against resistance, facilitation of high functional positions such as sedentary, bipedal and walking were applied, according to conventional treatment protocol.
Other: Star to move Protocol
Progressive physical therapy according to the Gosslink protocol called "Start to move".
Change of ICU-acquired weakness
ICU-AW was measured through the MRC scale of 60 points, where scores below 48 points indicate ICU-AW and more than 48 points the greater the strength of the subject.
Time frame: It is measured in the first 24 hours of the awakening phase of the patient in the 24 hours prior to discharge from the ICU.
Change of Functionality of the Critically Ill Patient (Intra-hospital)
Through the FSS-ICU evaluation scale, a score of 0 to 35 points is made to evaluate the motor function of the critical patient, where the higher the score, the greater the subject's functionality.
Time frame: It is measured in the first 24 hours of the awakening phase of the patient in the 24 hours prior to discharge from the ICU.
Change of Functionality of the Critically Ill Patient (pre-hospitalization)
Evaluation of the Barthel index of a family member, of the baseline state of the patient, before hospitalization. The total score is 100 points, the higher the score, the better the patient's baseline functionality.
Time frame: It is measured in the first 24 hours of the awakening phase of the patient in the 24 hours prior to discharge from the ICU.
Change of Delirium
It is measured using the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) scale to determine the presence of delirium. It does not have a score, if it meets criteria the subject will have delirium.
Time frame: It is measured in the first 24 hours of the awakening phase of the patient in the 24 hours prior to discharge from the ICU.
ICU stay (days)
Number of days hospitalized in ICU, up to 45 days. From the date of admission to the ICU until the departure from the ICU.
Time frame: It is measured in the 24 hours prior to discharge from the ICU.
Days of invasive mechanical ventilation (IMV)
Number of days of invasive mechanical ventilation during hospitalization, up to 45 days. From the day of intubation until weaning from invasive mechanical ventilation.
Time frame: It is measured in the 24 hours prior to discharge from the ICU.
Mortality at 28 days, post ICU discharge
The patient's death is verified according to the medical record (during hospitalization) or through a telephone number to a family member (outside the hospital).
Time frame: Measured at 28 days post ICU discharge.
Plan to share: No — Data were recorded using an Epidata form.
This study is completed, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.